Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Gilead Sciences Profit Margin 2006-2020 | GILD

Current and historical gross margin, operating margin and net profit margin for Gilead Sciences (GILD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Gilead Sciences net profit margin as of June 30, 2020 is -1.16%.
  
Gilead Sciences Annual Profit Margins
Gilead Sciences Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $85.479B $22.449B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $143.093B 11.02
Amgen (AMGN) United States $140.836B 15.30
CSL (CSLLY) Australia $90.247B 0.00
Vertex Pharmaceuticals (VRTX) United States $69.584B 38.83
Regeneron Pharmaceuticals (REGN) United States $67.209B 24.85
Illumina (ILMN) United States $51.969B 60.02
Biogen (BIIB) United States $45.680B 7.82
Seattle Genetics (SGEN) United States $27.864B 0.00
Moderna (MRNA) United States $26.765B 0.00
Genmab (GMAB) Denmark $24.812B 15.69
Genmab (GNMSF) Denmark $23.287B 5.36
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $22.470B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.332B 9.31
BioMarin Pharmaceutical (BMRN) United States $21.194B 153.78
Incyte (INCY) United States $20.899B 0.00
BeiGene (BGNE) Cayman Islands $19.246B 0.00
BioNTech SE (BNTX) Germany $16.065B 0.00
Alnylam Pharmaceuticals (ALNY) United States $15.938B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.037B 68.01
Horizon Therapeutics Public (HZNP) Ireland $14.950B 34.98
Exact Sciences (EXAS) United States $13.095B 0.00
Galapagos (GLPG) Belgium $12.622B 45.73
Sarepta Therapeutics (SRPT) United States $12.482B 0.00
ARGENX SE-ADR (ARGX) Netherlands $11.160B 0.00
QIAGEN (QGEN) Netherlands $11.080B 28.12
Bio-Techne Corp (TECH) United States $10.178B 70.45
Immunomedics (IMMU) United States $9.398B 0.00
Guardant Health (GH) United States $8.891B 0.00
Novavax (NVAX) United States $8.167B 0.00
Repligen (RGEN) United States $7.679B 121.88
Ascendis Pharma (ASND) Denmark $7.534B 0.00
Emergent Biosolutions (EBS) United States $7.142B 28.29
Exelixis (EXEL) United States $6.807B 24.75
Vir Biotechnology (VIR) United States $6.702B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $6.600B 16.42
CRISPR Therapeutics AG (CRSP) Switzerland $6.438B 199.43
ACADIA Pharmaceuticals (ACAD) United States $6.293B 0.00
Mirati Therapeutics (MRTX) United States $6.141B 0.00
Acceleron Pharma (XLRN) United States $5.561B 0.00
MyoKardia (MYOK) United States $5.389B 0.00
Adaptive Biotechnologies (ADPT) United States $5.364B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.204B 0.00
Zai Lab (ZLAB) China $4.723B 0.00
NeoGenomics (NEO) United States $4.447B 1342.33
MorphoSys AG (MOR) Germany $4.297B 56.31
China Biologic Products (CBPO) China $4.212B 23.42
Blueprint Medicines (BPMC) United States $4.160B 0.00
Halozyme Therapeutics (HALO) United States $4.060B 0.00
Bluebird Bio (BLUE) United States $4.033B 0.00
Global Blood Therapeutics (GBT) United States $3.799B 0.00
Amicus Therapeutics (FOLD) United States $3.799B 0.00
Arena Pharmaceuticals (ARNA) United States $3.766B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.554B 0.00
Reata Pharmaceuticals (RETA) United States $3.471B 0.00
Denali Therapeutics (DNLI) United States $3.163B 0.00
Sorrento Therapeutics (SRNE) United States $3.149B 0.00
Principia Biopharma (PRNB) United States $3.049B 0.00
Fate Therapeutics (FATE) United States $3.040B 0.00
Alkermes (ALKS) Ireland $2.992B 62.70
Twist Bioscience (TWST) United States $2.908B 0.00
Insmed (INSM) United States $2.863B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.664B 0.00
Amarin (AMRN) Ireland $2.606B 0.00
Inovio Pharmaceuticals (INO) United States $2.411B 0.00
Editas Medicine (EDIT) United States $2.199B 0.00
Seres Therapeutics (MCRB) United States $2.179B 0.00
Viela Bio (VIE) United States $2.114B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.926B 45.83
UniQure (QURE) Netherlands $1.853B 0.00
Ligand Pharmaceuticals (LGND) United States $1.820B 61.52
PHARMA MAR SA (PHMMF) Spain $1.797B 0.00
I-Mab (IMAB) China $1.711B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.710B 0.00
Eidos Therapeutics (EIDX) United States $1.648B 0.00
Sangamo Therapeutics (SGMO) United States $1.638B 0.00
Cytokineticsorporated (CYTK) United States $1.611B 0.00
Revance Therapeutics (RVNC) United States $1.602B 0.00
Arcus Biosciences (RCUS) United States $1.577B 0.00
Zealand Pharma (ZEAL) Denmark $1.477B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.427B 0.00
Coherus BioSciences (CHRS) United States $1.391B 8.11
Mesoblast (MESO) Australia $1.379B 0.00
Zymeworks (ZYME) Canada $1.368B 0.00
Intra-Cellular Therapies (ITCI) United States $1.331B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.291B 0.00
Epizyme (EPZM) United States $1.290B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
Mersana Therapeutics (MRSN) United States $1.251B 0.00
REGENXBIO (RGNX) United States $1.235B 0.00
NGM Biopharmaceuticals (NGM) United States $1.233B 0.00
Intellia Therapeutics (NTLA) United States $1.205B 0.00
Compugen (CGEN) Israel $1.201B 0.00
Alcobra (ARCT) United States $1.167B 0.00
Beam Therapeutics (BEAM) United States $1.160B 0.00
Akcea Therapeutics (AKCA) United States $1.129B 0.00
Alector (ALEC) United States $1.086B 0.00
Arvinas (ARVN) United States $1.086B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.023B 0.00
Adverum Biotechnologies (ADVM) United States $1.009B 0.00
Heska (HSKA) United States $1.002B 0.00
NantKwest (NK) United States $1.002B 0.00
Myriad Genetics (MYGN) United States $0.998B 0.00
Retrophin (RTRX) United States $0.949B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.935B 0.00
Athenex (ATNX) United States $0.929B 0.00
Morphic Holding (MORF) United States $0.923B 0.00
VBI Vaccines (VBIV) United States $0.869B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.834B 0.00
Castle Biosciences (CSTL) United States $0.808B 0.00
Pharming Group (PHGUF) Netherlands $0.801B 18.29
Codexis (CDXS) United States $0.793B 0.00
Cara Therapeutics (CARA) United States $0.791B 0.00
Dynavax Technologies (DVAX) United States $0.746B 0.00
Frequency Therapeutics (FREQ) United States $0.738B 0.00
Cellectis S.A (CLLS) France $0.721B 0.00
Intrexon (PGEN) United States $0.720B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.720B 0.00
Kadmon Holdings (KDMN) United States $0.714B 0.00
Vericel (VCEL) United States $0.708B 0.00
MiMedx (MDXG) United States $0.703B 0.00
Agenus (AGEN) United States $0.695B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.649B 5.68
ZIOPHARM Oncology Inc (ZIOP) United States $0.648B 0.00
Protagonist Therapeutics (PTGX) United States $0.642B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Cue Biopharma (CUE) United States $0.614B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.608B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Syros Pharmaceuticals (SYRS) United States $0.552B 0.00
Geron (GERN) United States $0.518B 0.00
Anika Therapeutics (ANIK) United States $0.516B 22.57
Biofrontera AG (BFRA) Germany $0.514B 0.00
Prothena (PRTA) Ireland $0.508B 0.00
MeiraGTx Holdings (MGTX) United States $0.507B 0.00
Cel-Sci (CVM) United States $0.504B 0.00
Kala Pharmaceuticals (KALA) United States $0.501B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.500B 0.00
Innate Pharma S.A (IPHA) France $0.485B 0.00
UROGEN PHARMA (URGN) United States $0.484B 0.00
AnaptysBio (ANAB) United States $0.482B 0.00
Athersys (ATHX) United States $0.476B 0.00
AC Immune SA (ACIU) Switzerland $0.470B 0.00
Avid Bioservices (CDMO) United States $0.470B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.459B 0.00
BioDelivery Sciences (BDSI) United States $0.458B 32.43
Pfenex (PFNX) United States $0.439B 0.00
Clovis Oncology (CLVS) United States $0.431B 0.00
Scholar Rock Holding (SRRK) United States $0.410B 0.00
ANI Pharmaceuticals (ANIP) United States $0.408B 9.62
IVERIC Bio (ISEE) United States $0.406B 0.00
Celldex Therapeutics (CLDX) United States $0.403B 0.00
Kamada (KMDA) Israel $0.401B 19.15
Prometic Life Sciences (LMNL) Canada $0.393B 0.00
Puma Biotechnology (PBYI) United States $0.393B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.382B 0.00
Merus (MRUS) Netherlands $0.378B 0.00
MannKind (MNKD) United States $0.376B 0.00
PDL BioPharma (PDLI) United States $0.374B 0.00
Cellular Biomedicine (CBMG) United States $0.368B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.362B 0.00
Albireo Pharma (ALBO) United States $0.354B 0.00
WAVE Life Sciences (WVE) Singapore $0.334B 0.00
Precision BioSciences (DTIL) United States $0.327B 0.00
CytomX Therapeutics (CTMX) United States $0.323B 0.00
IBio (IBIO) United States $0.315B 0.00
Sutro Biopharma (STRO) United States $0.314B 0.00
Trevena (TRVN) United States $0.312B 0.00
OSMOTICA PHARM (OSMT) United States $0.308B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.302B 0.00
ChromaDex (CDXC) United States $0.299B 0.00
Selecta Biosciences (SELB) United States $0.280B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.280B 0.00
Arbutus Biopharma (ABUS) United States $0.278B 0.00
Starpharma Holdings (SPHRY) Australia $0.277B 0.00
Menlo Therapeutics (MNLO) United States $0.272B 0.00
Affimed (AFMD) Germany $0.262B 0.00
ADMA Biologics Inc (ADMA) United States $0.262B 0.00
Fortress Biotech (FBIO) United States $0.261B 0.00
Spero Therapeutics (SPRO) United States $0.260B 0.00
DBV Technologies S.A (DBVT) France $0.259B 0.00
Verastem (VSTM) United States $0.258B 0.00
NextCure (NXTC) United States $0.256B 0.00
Northwest Biotherapeutics (NWBO) United States $0.245B 0.00
Dyadic (DYAI) United States $0.244B 0.00
Abeona Therapeutics (ABEO) United States $0.240B 0.00
Forte Biosciences (FBRX) United States $0.239B 0.00
HOOKIPA Pharma (HOOK) United States $0.234B 0.00
Pluristem Therapeutics (PSTI) Israel $0.222B 0.00
Liquidia Technologies (LQDA) United States $0.220B 0.00
Theratechnologies (THTX) Canada $0.210B 0.00
Strongbridge Biopharma (SBBP) United States $0.206B 0.00
XOMA (XOMA) United States $0.205B 0.00
Aduro Biotech (ADRO) United States $0.201B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.197B 9.20
GENFIT S.A (GNFT) France $0.195B 0.00
Exicure (XCUR) United States $0.195B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.192B 0.00
Cerecor (CERC) United States $0.189B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.184B 0.00
Aptinyx (APTX) United States $0.179B 0.00
Five Prime Therapeutics (FPRX) United States $0.174B 0.00
VTv Therapeutics (VTVT) United States $0.171B 0.00
Cyclerion Therapeutics (CYCN) United States $0.171B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.163B 0.00
Bellus Health (BLU) Canada $0.161B 0.00
TELA Bio (TELA) United States $0.159B 0.00
Kindred Biosciences (KIN) United States $0.157B 0.00
Aytu Bioscience (AYTU) United States $0.156B 0.00
Cidara Therapeutics (CDTX) United States $0.155B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Applied Genetic Technologies (AGTC) United States $0.144B 0.00
Celyad SA (CYAD) Belgium $0.141B 0.00
Eton Pharmaceuticals (ETON) United States $0.140B 0.00
VolitionRX (VNRX) United States $0.138B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.138B 0.00
Gritstone Oncology (GRTS) United States $0.138B 0.00
Cardiff Oncology (CRDF) United States $0.133B 0.00
CorMedix Inc (CRMD) United States $0.130B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.130B 0.00
Lumos Pharma (LUMO) United States $0.127B 0.00
Orgenesis (ORGS) United States $0.126B 6.42
SESEN BIO, INC (SESN) United States $0.123B 0.00
Palatin Technologies (PTN) United States $0.123B 3.14
Oncobiologics (OTLK) United States $0.122B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.122B 0.00
PHASEBIO PHARMA (PHAS) United States $0.121B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
Catalyst Biosciences (CBIO) United States $0.119B 0.00
Checkpoint Therapeutics (CKPT) United States $0.115B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
Windtree Therapeutics (WINT) United States $0.108B 0.00
Cocrystal Pharma (COCP) United States $0.101B 0.00
Antibe Therapeutics (ATBPF) Canada $0.098B 0.00
AIT Therapeutics (XAIR) United States $0.097B 0.00
ARAVIVE, INC (ARAV) United States $0.095B 0.00
Organovo Holdings (ONVO) United States $0.093B 0.00
Vaccinex (VCNX) United States $0.091B 0.00
Unum Therapeutics (UMRX) United States $0.091B 0.00
AquaBounty Technologies (AQB) United States $0.081B 0.00
Adocia (ADOCY) France $0.080B 0.00
Synlogic (SYBX) United States $0.080B 0.00
AnPac Bio-Medical Science (ANPC) China $0.079B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
Clearside Biomedical (CLSD) United States $0.077B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.077B 0.00
DiaMedica Therapeutics (DMAC) United States $0.076B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.076B 0.00
Emmaus Life Sciences (EMMA) United States $0.072B 0.00
Proteostasis Therapeutics (PTI) United States $0.072B 0.00
Edesa Biotech (EDSA) Canada $0.068B 0.00
Idera Pharmaceuticals (IDRA) United States $0.068B 0.00
Curis (CRIS) United States $0.068B 0.00
Bionano Genomics (BNGO) United States $0.064B 0.00
Signal Genetics (MGEN) United States $0.063B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.063B 0.00
Stealth BioTherapeutics (MITO) United States $0.063B 89.50
Aridis Pharmaceuticals (ARDS) United States $0.061B 0.00
Soligenix (SNGX) United States $0.060B 0.00
Happiness Biotech Group (HAPP) China $0.058B 0.00
IMMURON (IMRN) Australia $0.057B 0.00
Vascular Biogenics (VBLT) Israel $0.054B 0.00
Genetic Technologies (GENE) Australia $0.054B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.053B 0.00
CollPlant Holdings (CLGN) Israel $0.052B 0.00
Prima BioMed (IMMP) Australia $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.048B 0.00
Novogen (KZIA) Australia $0.045B 0.00
Pulmatrix (PULM) United States $0.040B 0.00
Prana Biotechnology (ATHE) Australia $0.038B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
AmpliPhi Biosciences (ARMP) United States $0.037B 0.00
Celsion (CLSN) United States $0.036B 0.00
OvaScience (MLND) United States $0.035B 0.00
Evogene (EVGN) Israel $0.034B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.034B 0.00
Acorda Therapeutics (ACOR) United States $0.033B 0.00
Advaxis (ADXS) United States $0.033B 0.00
Alimera Sciences (ALIM) United States $0.032B 0.00
Spherix (AIKI) United States $0.031B 0.00
Cleveland BioLabs (CBLI) United States $0.030B 0.00
Cesca Therapeutics (THMO) United States $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.026B 0.00
Chanticleer Holdings (SONN) United States $0.025B 0.00
Aptevo Therapeutics (APVO) United States $0.024B 0.00
BioPharmX (TMBR) United States $0.023B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
MYOS RENS Technology (MYOS) United States $0.018B 0.00
BioCardia (BCDA) United States $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.015B 0.00
Neuralstem (SNCA) United States $0.013B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00